Document Detail


Atrial fibrillation: the beat is faster than the answers.
MedLine Citation:
PMID:  22333744     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The prevalence of atrial fibrillation is much greater among persons with end-stage renal disease (ESRD) than among the general population. While significant advances have been made recently in the treatment of atrial fibrillation in the general population, we know very little about the treatment of atrial fibrillation among those with ESRD. This Commentary explores gaps in our knowledge of how to treat this vulnerable and sick population.
Authors:
Lynda A Szczech
Related Documents :
12742984 - Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial...
12835664 - A1-receptor blockade: a novel approach for assessing myocardial viability in chronic is...
7898094 - Organ protection: benefit from antihypertensive treatment?
10319084 - Cardiac production of angiotensin ii and its pharmacologic inhibition: effects on the c...
2494004 - Clot-selective coronary thrombolysis with pro-urokinase.
11872684 - Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Kidney international     Volume:  81     ISSN:  1523-1755     ISO Abbreviation:  Kidney Int.     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-02-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0323470     Medline TA:  Kidney Int     Country:  United States    
Other Details:
Languages:  eng     Pagination:  432-3     Citation Subset:  IM    
Affiliation:
Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chronic-on-acute kidney injury.
Next Document:  Interim fdg-pet predicts response and progression free survival in patients with hodgkin lymphoma an...